Adrenocorticotrophic hormone retarded metabolism of low-density lipoprotein in rats

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 3, 2004, Pages 217-222

  Xu, N ^a   Hurtig, M ^a   Ekstrom U ^a   Nilsson Ehle, P ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACTH; Apolipoprotein; Cholesterol; LDL; Lipoprotein receptor; Rat

Indexed keywords

APOLIPOPROTEIN E; CORTICOTROPIN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPECIES DIFFERENCE;

ADIPOSE TISSUE, BROWN; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BLOOD GLUCOSE; BRAIN CHEMISTRY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORTICOSTERONE; FATTY ACIDS; HUMANS; INTESTINE, SMALL; LIPOPROTEINS, LDL; LIVER; MALE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRIGLYCERIDES;

ANIMALIA; SUIDAE;

EID: 3042573782     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410005730     Document Type: Article

References (32)

1. Alfano J, Pedersen RC, Kramer RE, Brownie AC. Cholesterol metabolism in the rat adrenal cortex: acute temporal changes following stress. Can J Biochem Cell Biol 1983; 61: 708-13.
2. Berg AL, Hansson P, Nilsson-Ehle P. ACTH 1-24 decreases hepatic lipase activities and low density lipoprotein concentrations in healthy men. J Intern Med 1991; 229: 201-3.
3. Arnadottir M, Dallongeville J, Nilsson-Ehle P, Berg AL. Effects of short-term treatment with corticotropin on the serum apolipoprotein pattern. Scand J Clin Lab Invest 2001; 61: 301-6.
4. Arnadottir M, Berg AL, Kronenberg F, Lingenhel A, Hugosson T, Hegbrant J, Nilsson-Ehle P. Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: relation to apolipoprotein(a) size polymorphism. Metabolism 1999; 48: 342-6.
5. Berg AL, Nilsson-Ehle P, Arnadottir M. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 1999; 56: 1534-43.
6. Arnadottir M, Berg AL, Dallongeville J, Fruchart JC, Nilsson-Ehle P. Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations in hemodialysis patients. Kidney Int 1997; 52: 1651-5.
7. Hardarson A, Sigurdsson G, Olafsdottir E, Dallongeville J, Berg AL, Arnadottir M. Adrenocorticotrophic hormone exerts marked lipid-lowering effects in simvastatin-treated patients. J Intern Med 2001; 250: 530-4.
8. Berg AL, Nilsson-Ehle P. Direct effects of corticotropin on plasma lipoprotein metabolism in man - studies in vivo and in vitro. Metabolism 1994; 43: 90-7.
9. Berg AL, Nilsson-Ehle P. ACTH lowers serum lipids in steroid-treated hyperlipidemic patients with kidney disease. Kidney Int 1996; 50: 538-42.
10. Xu N, Ekstrom U, Nilsson-Ehle P. ACTH decreases the expression and secretion of apolipoprotein B in HepG2 cell cultures. J Biol Chem 2001; 276: 38680-4.
11. Bartens W, Kramer-Guth A, Wanner C. Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL) - but not of oxidized LDL and native or oxidized lipoprotein(a) [Lp(a)] - in HEPG2 cells: no evidence for Lp(a) catabolism via the LDL-receptor. Metabolism 1997; 46: 726-9.
12. Lehoux JG, Lefebvre A. Short-term effects of ACTH on the low-density lipoprotein receptor mRNA level in rat and hamster adrenals. J Mol Endocrinol 1991; 6: 223-30.
13. Kovanen PT, Goldstein JL, Chappell DA, Brown MS. Regulation of low density lipoprotein receptors by adrenocorticotropin in the adrenal gland of mice and rats in vivo. J Biol Chem 1980; 255: 5591-8.
14. Heikkila P, Arola J, Liu J, Kahri AI. ACTH regulates LDL receptor and CLA-1 mRNA in the rat adrenal cortex. Endocr Res 1998; 24: 591-3.
15. Rigotti A, Edelman ER, Seifert P, Iqbal SN, DeMattos RB, Temel RE, Krieger M, Williams DL. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J Biol Chem 1996; 271: 33545-9.
16. Cao G, Zhao L, Stangl H, Hasegawa T, Richardson JA, Parker KL, Hobbs HH. Developmental and hormonal regulation of murine scavenger receptor, class B, type 1. Mol Endocrinol 1999; 13: 1460-73.
17. Greene DJ, Skeggs JW, Morton RE. Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI). J Biol Chem 2001; 276: 4804-11.
18. Liu J, Voutilainen R, Heikkila P, Kahri AI. Ribonucleic acid expression of the CLA-1 gene, a human homolog to mouse high density lipoprotein receptor SR-BI, in human adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 1997; 82: 2522-7.
19. Landschulz KT, Pathak RK, Rigotti A, Krieger M, Hobbs HH. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 1996; 98: 984-95.
20. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, Rothblat GH, Swaney JB, Tall AR. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272: 20982-5.
21. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982; 28: 1379-88.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
23. Fraker PJ, Speck JC, Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenyl-glycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
24. Meresse S, Delbart C, Fruchart JC, Cecchelli R. Low-density lipoprotein receptor on endothelium of brain capillaries. J Neurochem 1989; 53: 340-5.
25. Lucarelli M, Gennarelli M, Cardelli P, Novelli G, Scarpa S, Dallapiccola B, Strom R. Expression of receptors for native and chemically modified low-density lipoproteins in brain microvessels. FEBS Lett 1997; 401: 53-8.
26. Herz J. LRP: a bright beacon at the blood-brain barrier. J Clin Invest 2003; 112: 1483-5.
27. Triguero D, Buciak J, Pardridge WM. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 1990; 54: 1882-8.
28. Galman C, Angelin B, Rudling M. Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol. Endocrinology 2002; 143: 1809-16.
29. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994; 269: 21003-9.
30. Murao K, Terpstra V, Green SR, Kondratenko N, Steinberg D, Quehenberger O. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997; 272: 17551-7.
31. Liu J, Heikkila P, Meng QH, Kahri AI, Tikkanen MJ, Voutilainen R. Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol 2000; 142: 677-82.
32. Wang N, Arai T, Ji Y, Rinninger F, Tall AR. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 1998; 273: 32920-6.